Pfizer close to applying for vaccine authorisation
By Rob Freeman | 18th November 2020
Pfizer and BioNTech are set to submit their coronavirus vaccine for emergency authorisation "within days" after further tests proved it was 95 per cent effective.
The companies said it would apply to the US regulator after the latest tests met safety criteria.
And the Medicine and Healthcare products Regulatory Agency is poised to fast track the vaccine in the UK with health secretary Matt Hancock saying it could be rolled out from December 1.
The UK has ordered enough doses for 20 million people and should receive around one quarter of them before the end of this year.
Latest test results, which follow the preliminary Phase 3 trials published last week, showed 95 per cent of patients were protected within 28 days of the first dose and 94 per cent effective among over 65s.
Around two per cent of volunteers experienced headaches and fatigue with no serious side-effects.
Pfizer and BioNTech predict they will produce up to 1.3 billion doses by the end of next year.
Earlier this week US company Moderna reported its vaccine was also 95 per cent effective while Oxford University and AstraZeneca are expected to publish tests results on their vaccine in the coming weeks.
Copyright 2021 Moose Partnership Ltd. All rights reserved. Reproduction of any content is strictly forbidden without prior permission.